Should You Exit Option Care Health (OPCH)?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, its Investor Class fund ARTSX returned 1.10%, Advisor Class fund APDSX posted a return of 1.19%, and Institutional Class fund APHSX returned 1.19%, compared to a return of 7.05% for the Russell 2000 Growth Index. Year-to-date, ARTSX, APDSX, and APHSX returned 8.78%, 8.91%, and 8.91%, respectively, compared to a 13.55% return for the benchmark. Despite this year’s relative setback, the firm remains bullish on its asset class’s long-term prospects. In addition, please check the fund’s top five holdings to know its best picks in 2023.

Artisan Small Cap Fund highlighted stocks like Option Care Health, Inc. (NASDAQ:OPCH) in the second quarter 2023 investor letter. Headquartered in Bannockburn, Illinois, Option Care Health, Inc. (NASDAQ:OPCH) provides home and alternate site infusion services. On August 30, 2023, Option Care Health, Inc. (NASDAQ:OPCH) stock closed at $35.23 per share. One-month return of Option Care Health, Inc. (NASDAQ:OPCH) was 4.82%, and its shares gained 14.94% of their value over the last 52 weeks. Option Care Health, Inc. (NASDAQ:OPCH) has a market capitalization of $6.337 billion.

Artisan Small Cap Fund made the following comment about Option Care Health, Inc. (NASDAQ:OPCH) in its second quarter 2023 investor letter:

“Along with Catalent, we ended our investment campaigns in Chegg and Option Care Health, Inc. (NASDAQ:OPCH). Option Care Health is the largest independent provider of home infusion services in the US. The company is capitalizing on several secular growth tailwinds: an aging population, a growing number of drugs requiring infusion and payers’ financial incentive to move patients toward lower cost of care environments (Option Care infusions are up to 50% less than those at hospitals). During the quarter, the company announced an acquisition, which could be transformational but would change our thesis. With a long-term view, we still believe Option Care can be a leader in the home provider market, but this deal adds integration risks, and we decided to exit the position.”

nuclear medicine work

Photo by ani-kolleshi on unsplash

Option Care Health, Inc. (NASDAQ:OPCH) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 43 hedge fund portfolios held Option Care Health, Inc. (NASDAQ:OPCH) at the end of second quarter which was 36 in the previous quarter.

We discussed Option Care Health, Inc. (NASDAQ:OPCH) in another article and shared Stanley Druckenmiller’s 13F portfolio and its top 15 stock picks. In addition, please check out our hedge fund investor letters Q2 2023 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.